PHARMEDIC JSC
PHARMEDIC JSC operates in Pharmaceuticals.
Market Cap & Net Worth: PHARMEDIC JSC (PMC)
PHARMEDIC JSC (VN:PMC) has a market capitalization of $55.53K (₫1.41 Billion) as of March 18, 2026. Listed on the VN stock exchange, this Vietnam-based company holds position #42092 globally and #311 in its home market, demonstrating a -3.38% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying PHARMEDIC JSC's stock price ₫142900.00 by its total outstanding shares 9874 (9.87K).
PHARMEDIC JSC Market Cap History: 2015 to 2026
PHARMEDIC JSC's market capitalization history from 2015 to 2026. Data shows growth from $9.91K to $55.53K (18.79% CAGR).
Index Memberships
PHARMEDIC JSC is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
HNX
HNXI
|
$1.88 Million | 2.99% | #5 of 302 |
|
HNX Mid/Small Cap
HNXMSC
|
$1.35 Million | 4.15% | #4 of 245 |
Weight: PHARMEDIC JSC's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
PHARMEDIC JSC Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how PHARMEDIC JSC's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of PMC by Market Capitalization
Companies near PHARMEDIC JSC in the global market cap rankings as of March 18, 2026.
Key companies related to PHARMEDIC JSC by market ranking:
- Sam Chun Dang Pharm. Co. Ltd (KQ:000250): Ranked #3465 globally with a market cap of $3.69 Billion USD ( ₩5.41 Trillion KRW).
- Mezzion Pharma Co.Ltd (KQ:140410): Ranked #6393 globally with a market cap of $1.27 Billion USD ( ₩1.86 Trillion KRW).
- ST Pharm Co.Ltd (KQ:237690): Ranked #7113 globally with a market cap of $1.05 Billion USD ( ₩1.54 Trillion KRW).
- Oscotec Inc (KQ:039200): Ranked #7795 globally with a market cap of $890.75 Million USD ( ₩1.30 Trillion KRW).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #3465 | Sam Chun Dang Pharm. Co. Ltd | KQ:000250 | $3.69 Billion | ₩739000.00 |
| #6393 | Mezzion Pharma Co.Ltd | KQ:140410 | $1.27 Billion | ₩89200.00 |
| #7113 | ST Pharm Co.Ltd | KQ:237690 | $1.05 Billion | ₩153400.00 |
| #7795 | Oscotec Inc | KQ:039200 | $890.75 Million | ₩54900.00 |
PHARMEDIC JSC Historical Marketcap From 2015 to 2026
Between 2015 and today, PHARMEDIC JSC's market cap moved from $9.91K to $ 55.53K, with a yearly change of 18.79%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₫55.53K | -13.50% |
| 2025 | ₫64.20K | +58.85% |
| 2024 | ₫40.42K | +30.44% |
| 2023 | ₫30.98K | +20.18% |
| 2022 | ₫25.78K | +34.70% |
| 2021 | ₫19.14K | +18.01% |
| 2020 | ₫16.22K | +13.97% |
| 2019 | ₫14.23K | -3.19% |
| 2018 | ₫14.70K | -13.29% |
| 2017 | ₫16.95K | +1.73% |
| 2016 | ₫16.66K | +68.16% |
| 2015 | ₫9.91K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of PHARMEDIC JSC was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $55.53K USD |
| MoneyControl | $55.53K USD |
| MarketWatch | $55.53K USD |
| marketcap.company | $55.53K USD |
| Reuters | $55.53K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.